Naoki Hirose

T&C Medical Science, Inc. engages in the medical, financial advisory and food businesses. It operates through the following segments: Medical, Exchange Traded Fund (ETF), Financial Advisory and Licensing. The Medical segment engages in the business of regenerative medicine by uena factors, medical device sale and operational management of hospitals. The ETF segment offers ETF database and analysis tools to financial institutions and institutional investors. The Financial Advisory segment deals with fund management and operations, and investment scheme advisory services. The Licensing segment engages in the manufacture and sale of medical equipment. The company was founded on August 13, 2001 and is headquartered in Tokyo, Japan.